The exploration of novel Alzheimer's therapeutic agents from the pool of FDA approved medicines using drug repositioning, enzyme inhibition and kinetic mechanism approaches

Hassan, M; Raza, H; Abbasi, MA; Moustafa, AA; Seo, SY

Seo, SY (reprint author), Kongju Natl Univ, Coll Nat Sci, Dept Biol Sci, Gongju 32588, South Korea.

BIOMEDICINE & PHARMACOTHERAPY, 2019; 109 (): 2513

Abstract

Novel drug development is onerous, time consuming and overpriced process with particularly low success and relatively high enfeebling rates. To overco......

Full Text Link